Journal of Genetic Medicine

Korean Society of Medical Genetics and Genomics (대한의학유전학회)
권호 표지
DOI QR코드

DOI QR Code

Prenatal molecular diagnosis and carrier detection of Duchenne muscular dystrophy in Korea

  • Kang, Min Ji (Department of Obstetrics and Gynecology, Seoul National University College of Medicine) ;
  • Seong, Moon-Woo (Department of Laboratory Medicine, Seoul National University College of Medicine) ;
  • Cho, Sung Im (Department of Laboratory Medicine, Seoul National University College of Medicine) ;
  • Park, Joong Shin (Department of Obstetrics and Gynecology, Seoul National University College of Medicine) ;
  • Jun, Jong Kwan (Department of Obstetrics and Gynecology, Seoul National University College of Medicine) ;
  • Park, Sung Sup (Department of Laboratory Medicine, Seoul National University College of Medicine)
  • Received : 2020.06.02
  • Accepted : 2020.06.10
  • Published : 2020.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Duchenne muscular dystrophy (DMD) is the most common lethal muscular dystrophy and is caused by the genetic variants of DMD gene. Because DMD is X-linked recessive and shows familial aggregates, prenatal diagnosis is an important role in the management of DMD family. We present our experience of prenatal molecular diagnosis and carrier detection based on multiplex polymerase chain reaction (PCR), multiplex ligation-dependent probe amplification (MLPA), and linkage analysis. Materials and Methods: During study period, 34 cases of prenatal diagnosis and 21 cases of carrier detection were performed at the Seoul National University Hospital. Multiplex PCR and MLPA was used to detect the exon deletions or duplications. When the DMD pathogenic variant in the affected males is unknown and no DMD pathogenic variant is detected in atrisk females, linkage analysis was used. Results: The prenatal molecular diagnosis was offered to 34 fetuses. Twenty-five fetuses were male and 6 fetuses (24.0%) were affected. Remaining cases had no pathogenic mutation. We had 24 (80.0%) cases of known proband results; exon deletion mutation in 19 (79.2%) cases and duplication in 5 (20.8%) cases. Linkage analysis was performed in 4 cases in which 2 cases (50.0%) were found to be affected. In the carrier testing, among 21 cases including 15 cases of mother and 6 cases of female relative, 9 (42.9%) cases showed positive results and 12 (57.1%) cases showed negative results. Conclusion: Prenatal molecular diagnosis and carrier detection of DMD are effective and feasible. They are useful in genetic counseling for DMD families.

Keywords

References

  1. Emery AE. The muscular dystrophies. Lancet 2002;359:687-95. https://doi.org/10.1016/S0140-6736(02)07815-7
  2. Ellis JA, Vroom E, Muntoni F. 195th ENMC International workshop: newborn screening for Duchenne muscular dystrophy 14-16th December, 2012, Naarden, The Netherlands. Neuromuscul Disord 2013;23:682-9. https://doi.org/10.1016/j.nmd.2013.05.008
  3. Hoffman EP, Brown RH Jr, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987;51:919-28. https://doi.org/10.1016/0092-8674(87)90579-4
  4. Murray JM, Davies KE, Harper PS, Meredith L, Mueller CR, Williamson R. Linkage relationship of a cloned DNA sequence on the short arm of the X chromosome to Duchenne muscular dystrophy. Nature 1982;300:69-71. https://doi.org/10.1038/300069a0
  5. Muntoni F, Torelli S, Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2003;2:731-40. https://doi.org/10.1016/S1474-4422(03)00585-4
  6. Bakker E, Hofker MH, Goor N, Mandel JL, Wrogemann K, Davies KE, et al. Prenatal diagnosis and carrier detection of Duchenne muscular dystrophy with closely linked RFLPs. Lancet 1985;1:655-8.
  7. Abbs S, Tuffery-Giraud S, Bakker E, Ferlini A, Sejersen T, Mueller CR. Best practice guidelines on molecular diagnostics in Duchenne/Becker muscular dystrophies. Neuromuscul Disord 2010;20:422-7. https://doi.org/10.1016/j.nmd.2010.04.005
  8. Xu Y, Li X, Ge HJ, Xiao B, Zhang YY, Ying XM, et al. Haplotype-based approach for noninvasive prenatal tests of Duchenne muscular dystrophy using cell-free fetal DNA in maternal plasma. Genet Med 2015;17:889-96. https://doi.org/10.1038/gim.2014.207
  9. Helderman-van den Enden AT, Madan K, Breuning MH, van der Hout AH, Bakker E, de Die-Smulders CE, et al. An urgent need for a change in policy revealed by a study on prenatal testing for Duchenne muscular dystrophy. Eur J Hum Genet 2013;21:21-6. https://doi.org/10.1038/ejhg.2012.101
  10. Monaco AP, Neve RL, Colletti-Feener C, Bertelson CJ, Kurnit DM, Kunkel LM. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 1986;323:646-50. https://doi.org/10.1038/323646a0
  11. Kunkel LM, Hejtmancik JF, Caskey CT, Speer A, Monaco AP, Middlesworth W, et al. Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature 1986;322:73-7. https://doi.org/10.1038/322073a0
  12. Aartsma-Rus A, Ginjaar IB, Bushby K. The importance of genetic diagnosis for Duchenne muscular dystrophy. J Med Genet 2016;53:145-51. https://doi.org/10.1136/jmedgenet-2015-103387
  13. Wang H, Xu Y, Liu X, Wang L, Jiang W, Xiao B, et al. Prenatal diagnosis of Duchenne muscular dystrophy in 131 Chinese families with dystrophinopathy. Prenat Diagn 2017;37:356-64. https://doi.org/10.1002/pd.5019
  14. Cho A, Seong MW, Lim BC, Lee HJ, Byeon JH, Kim SS, et al. Consecutive analysis of mutation spectrum in the dystrophin gene of 507 Korean boys with Duchenne/Becker muscular dystrophy in a single center. Muscle Nerve 2017;55:727-34. https://doi.org/10.1002/mus.25396
  15. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002;30:e57. https://doi.org/10.1093/nar/gnf056
  16. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al; DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 2010;9:177-89. https://doi.org/10.1016/S1474-4422(09)70272-8
  17. Bakker E, Van Broeckhoven C, Bonten EJ, van de Vooren MJ, Veenema H, Van Hul W, et al. Germline mosaicism and Duchenne muscular dystrophy mutations. Nature 1987;329:554-6. https://doi.org/10.1038/329554a0
  18. Darras BT, Francke U. A partial deletion of the muscular dystrophy gene transmitted twice by an unaffected male. Nature 1987;329:556-8. https://doi.org/10.1038/329556a0
  19. Wang Y, Yang Y, Liu J, Chen XC, Liu X, Wang CZ, et al. Whole dystrophin gene analysis by next-generation sequencing: a comprehensive genetic diagnosis of Duchenne and Becker muscular dystrophy. Mol Genet Genomics 2014;289:1013-21. https://doi.org/10.1007/s00438-014-0847-z
  20. Bermudez-Lopez C, Garcia-de Teresa B, Gonzalez-del Angel A, Alcantara-Ortigoza MA. Germinal mosaicism in a sample of families with Duchenne/Becker muscular dystrophy with partial deletions in the DMD gene. Genet Test Mol Biomarkers 2014;18:93-7. https://doi.org/10.1089/gtmb.2013.0384
  21. Jang SS, Lim BC, Yoo SK, Shin JY, Kim KJ, Seo JS, et al. Targeted linkedread sequencing for direct haplotype phasing of maternal DMD alleles: a practical and reliable method for noninvasive prenatal diagnosis. Sci Rep 2018;8:8678. https://doi.org/10.1038/s41598-018-26941-0
  22. Prior TW, Bartolo C, Papp AC, Snyder PJ, Sedra MS, Burghes AH, et al. Dystrophin expression in a Duchenne muscular dystrophy patient with a frame shift deletion. Neurology 1997;48:486-8. https://doi.org/10.1212/WNL.48.2.486